SIRT1 induces mitochondrial biogenesis through the deacetylation of PGC1α and activation of AMPK and therefore increases fatty acid β-oxidation that may help to alleviate NAFLD [57]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.